Follow
Rameshwar S. Cheke
Rameshwar S. Cheke
PhD Research Scholar, Institute of Chemical Technology (ICT), Mumbai
No verified email
Title
Cited by
Cited by
Year
Recognition of Natural Products as Potential Inhibitors of COVID‑19 Main Protease (Mpro): In‑Silico Evidences
SD Narkhede, R.R., Pise, A.V., Cheke, R.S., Shinde
Natural Products and Bioprospecting, 2020
2012020
The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2
RR Narkhede, RS Cheke, JP Ambhore, SD Shinde
Eurasian Journal of Medicine and Oncology 4 (3), 185-195, 2020
1392020
Therapeutic outcomes of isatin and its derivatives against multiple diseases: Recent developments in drug discovery
RS Cheke, VM Patil, SD Firke, JP Ambhore, IA Ansari, HM Patel, ...
Pharmaceuticals 15 (3), 272, 2022
432022
Molecular insights into coumarin analogues as antimicrobial agents: Recent developments in drug discovery
RS Cheke, HM Patel, VM Patil, IA Ansari, JP Ambhore, SD Shinde, ...
Antibiotics 11 (5), 566, 2022
302022
Coronavirus: Hotspot on coronavirus disease 2019 in India
DC Rameshwar S. Cheke , Sachin Shinde, Jaya Ambhore, Vaibhav Adhao
Indian Journal of Medical Sciences 72 (1), 29-34, 2020
252020
Isatin: New hope against convulsion
RS Cheke, SD Firke, RR Patil, SB Bari
Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2018
242018
Recent advances in pharmacological diversification of Src family kinase inhibitors
P Negi, RS Cheke, VM Patil
Egyptian Journal of Medical Human Genetics 22, 1-16, 2021
182021
Quinazoline: An update on current status against convulsions
RS Cheke, SD Shinde, JP Ambhore, SR Chaudhari, SB Bari
Journal of Molecular Structure 1248, 131384, 2022
162022
Natural product emerging as potential SARS spike glycoproteins-ACE2 inhibitors to combat COVID-19 attributed by in-silico investigations
RS Cheke, RR Narkhede, SD Shinde, JP Ambhore, PG Jain
Biointerface Res. Appl. Chem 11, 10628-10639, 2021
162021
Discovery and Anticancer Activity of Novel 1,3,4-Thiadiazole- and Aziridine-Based Indolin-2-ones via In Silico Design Followed by Supramolecular Green Synthesis
PJ Chaudhari, SB Bari, SJ Surana, AA Shirkhedkar, CG Bonde, ...
ACS omega 7 (20), 17270-17294, 2022
132022
Futuristic review on progress in force degradation studies and stability indicating assay method for some antiviral drugs
JP Ambhore, VS Adhao, RS Cheke, RR Popat, SJ Gandhi
GSC Biological and Pharmaceutical Sciences 16 (1), 133-149, 2021
132021
Abrogation of cisplatin-induced nephrotoxicity in rats and HEK-293 cell lines by formononetin: in vivo and in vitro study
SD Shinde, PG Jain, RS Cheke, SJ Surana, SM Gunjegaonkar
Comparative Clinical Pathology 30 (4), 617-625, 2021
122021
The Berberis aristata Ameliorates oxazolone induced contact dermatitis: in-vivo and in silico evidences
SD Shinde, RS Cheke, PR Tathe, PG Jain, RR Narkhede
Advances in Traditional Medicine 21, 685-692, 2021
92021
A concise analytical profile of efavirenz: analytical methodologies
JP Ambhore, SR Chaudhari, RS Cheke, PS Kharkar
Critical Reviews in Analytical Chemistry 52 (7), 1583-1592, 2022
82022
Reverse phase-liquid chromatography assisted protocol for simultaneous determination of lamivudine and tenofovir disoproxil fumarate in combined medication used to control HIV …
VS Adhao, SR Chaudhari, JP Ambhore, S Sangolkar, RR Thenge, ...
Future Journal of Pharmaceutical Sciences 7, 1-11, 2021
82021
Recognition of natural products as potential inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences. Nat Prod Bioprospect. 2020; 10 (5): 297–306
RR Narkhede, AV Pise, RS Cheke, SD Shinde
doi. org/10.1007/s13659-020-00253-1, 0
7
Rationale design, synthesis, and pharmacological evaluation of isatin analogues as antiseizure agents
S Firke, R Cheke, V Ugale, S Khadse, M Gagarani, S Bari, S Surana
Letters in Drug Design & Discovery 18 (12), 1146-1164, 2021
62021
Molecular insights into resveratrol and its analogs as SARS-CoV-2 (COVID-19) protease inhibitors
VM Patil, RR Narkhede, N Masand, RS Cheke, K Balasubramanian
Coronaviruses 2 (11), 11-29, 2021
62021
Understanding the dynamics of COVID-19 outbreak: Structure, diagnosis, prevention and treatment
RR Narkhede, RS Cheke, SD Shinde, VG Kuchake, NM Mahajan, ...
Anti-Infective Agents 19 (4), 3-14, 2021
32021
Repurposing of anthelmintic drugs against SARS-CoV-2 (Mpro and RdRp): novel disease, older therapeutics
RS Cheke, RR Narkhede, SD Shinde, JP Ambhore, PG Jain
Letters in Applied NanoBioScience 10 (2), 2331-2338, 2020
32020
The system can't perform the operation now. Try again later.
Articles 1–20